February 2, 2026 · Form 4 insider transaction
Butler John P. sold 96,065 shares of Akreion Pharma Co at $1.39 per share, a transaction worth $133.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025.; This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31, 2024.